Looks like you’re on the UK site. Choose another location to see content specific to your location

Home Industry News Movetis wins awards for finance deals

Movetis wins awards for finance deals

4th October 2010

Movetis has won two industry awards in recognition of the value the company has delivered to shareholders with recent finance deals.

At the PharmaVentures European Deals 2010 Awards, Movetis was presented with the European financing deal of the year prize for its successful initial public offering on Euronext Brussels in late 2009.

In addition, the firm received the European merger and acquisition deal of the year award for the recent move by fellow pharmaceutical company Shire to purchase all of Movetis' outstanding shares and warrants.

The company expressed confidence that recent business deals such as these will position Movetis to become an increasingly major player in the European gastrointestinal market.

Catherine Moukheibir, chief financial officer of Movetis, said: "We are honoured to have received these awards which recognise Movetis' rapid development, its success and its creation of shareholder value since the company was founded in November 2006."

Last month, the company announced the commencement of a new phase III clinical trial for its constipation drug Resolor, in order to gauge its efficacy among male patients.ADNFCR-8000103-ID-800096298-ADNFCR

We currently have 5 jobs available in Pharmacy industry, find your perfect one now.

Stay informed

Receive the latest industry news, Tips
and straight to your inbox.